Recent advances in ADC design have led to a rapid increase in the number of approved agents for hematological cancers and solid tumors. Yet, as Torres explained, there are still important ...

The company’s antibody–drug conjugate (ADC) platform combines cutting edge effector chemistries, payloads, and linkers to enhance the efficacy and safety of ADCs. The key features of the ...

As the nature of applications has changed, the ADC naturally needs to evolve as well. The need for robust load balancing and application delivery techniques combined with robust security features ...